Skip to main content
AlzChem Group AG logo

AlzChem Group AG — Investor Relations & Filings

Ticker · ACT ISIN · DE000A2YNT30 LEI · 8945004EL7WZK3ERG181 F Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2024-12-09 Transaction in Own Shar…
Country DE Germany
Listing F ACT

About AlzChem Group AG

https://www.alzchem.com/en

AlzChem Group AG is a globally active, vertically integrated specialty chemicals company focused on NCN (Nitrogen-Carbon-Nitrogen) chemistry. Its production chain is based on raw materials such as calcium carbide and calcium cyanamide, from which it develops a wide range of products. The company serves diverse markets including human and animal nutrition, pharmaceuticals, agriculture, metallurgy, renewable energy, and automotive. Key products include high-purity creatine for dietary supplements (Creapure®), feed additives for animal nutrition (Creamino®), and high-purity guanidine salts used as intermediates for pharmaceutical and diagnostic applications, such as PCR tests. AlzChem also offers custom synthesis services and is a market leader in many of its business segments.

Recent filings

Filing Released Lang Actions
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 1st Interim Report
Transaction in Own Shares Classification · 100% confidence The document explicitly details the acquisition of shares by Alzchem Group AG as part of a previously announced share buyback programme, providing daily transaction volumes, weighted average prices, and aggregated volumes. This directly corresponds to the definition of 'Transaction in Own Shares' (POS). Although the title mentions '1st Interim Report', the content is exclusively about the share buyback disclosure required under EU regulations (Article 5 of EU Regulation 596/2014), not a comprehensive financial report (like 10-K or IR). The keyword 'Share Buyback' in the metadata further confirms this classification.
2024-12-09 English
Alzchem Group AG implements long-term succession planning for Management Board: Supervisory Board appoints Martina Spitzer as Chief Sales Officer effective January 1, 2025
Board/Management Information Classification · 100% confidence The document is a news release from Alzchem Group AG, dated December 4, 2024, announcing a change in senior management: the appointment of Martina Spitzer as Chief Sales Officer (CSO) effective January 1, 2025. This directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management. The presence of keywords like 'Management Board', 'Supervisory Board appoints', and 'Chief Sales Officer' confirms this classification. It is not a full financial report (10-K, IR) or an earnings release (ER).
2024-12-04 English
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - Share Repurchase
Transaction in Own Shares Classification · 100% confidence The document is a formal disclosure dated November 29, 2024, regarding the commencement of a share repurchase program by Alzchem Group AG. It explicitly references EU Regulations (596/2014 and 2016/1052) governing such transactions. The core subject is the company acquiring its own shares, which directly corresponds to the definition of 'Transaction in Own Shares'. The document is a regulatory announcement detailing the terms and start date of this buyback activity, fitting the 'POS' code perfectly. It is not a full annual report (10-K), an earnings release (ER), or a general management discussion (MDA).
2024-11-30 English
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - Share Repurchase
Transaction in Own Shares Classification · 100% confidence The document is a formal disclosure dated November 29, 2024, regarding the commencement of a share repurchase program by Alzchem Group AG. It explicitly references EU Regulations (596/2014 and 2016/1052) governing such transactions. The core subject is the company acquiring its own shares, which directly corresponds to the definition of 'Transaction in Own Shares'. The document is a regulatory announcement detailing the terms and start date of this buyback activity, fitting the 'POS' code perfectly. It is not a full annual report (10-K), an earnings release (ER), or a general management discussion (MDA).
2024-11-29 English
Alzchem Group AG: Dr. Georg Weichselbaumer, buy
Director's Dealing Classification · 100% confidence The document explicitly contains the header "Directors’ Dealings" and details a transaction (Acquisition) by a member of the managing body (Dr. Georg Weichselbaumer) of Alzchem Group AG. This directly corresponds to the definition of Director's Dealing, which is classified under the code DIRS.
2024-11-15 English
Alzchem Group AG: Klaus Dieter Englmaier, buy
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains detailed information regarding a transaction ('Acquisition') by a 'person discharging managerial responsibilities' (Klaus Dieter Englmaier, Member of the managing body) in the shares of Alzchem Group AG. This directly matches the definition for Director's Dealing (DIRS). The document structure and content are characteristic of insider transaction reporting.
2024-11-12 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.